107 related articles for article (PubMed ID: 3022444)
41. Effect of lymphokines on B-cell responses to Mycobacterium tuberculosis: a comparison of in vitro secreted antibodies by Epstein Barr virus transmitted B-cell and non-transformed peripheral blood B-cells from the same donor.
Githui WA
East Afr Med J; 1988 Dec; 65(12):829-37. PubMed ID: 2853043
[No Abstract] [Full Text] [Related]
42. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs.
Garzelli C; Taub FE; Scharff JE; Prabhakar BS; Ginsberg-Fellner F; Notkins AL
J Virol; 1984 Nov; 52(2):722-5. PubMed ID: 6092698
[TBL] [Abstract][Full Text] [Related]
43. EBV-activation of human B-lymphocytes.
Aman P; Lewin N; Nordström M; Klein G
Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
[No Abstract] [Full Text] [Related]
44. Epstein-Barr virus induced differentiation of early B-lineage cells.
Kubagawa H; Burrows PD; Grossi CE; Cooper MD
Curr Top Microbiol Immunol; 1986; 132():246-50. PubMed ID: 3024917
[No Abstract] [Full Text] [Related]
45. Probing the human B-cell repertoire: isolation of Epstein-Barr virus (EBV)-transformed human B lymphocytes making antibodies with a common idiotope that have different antigen-binding specificities.
Uchigata Y; Prabhakar BS; Notkins AL
J Clin Immunol; 1988 Nov; 8(6):459-63. PubMed ID: 2851610
[TBL] [Abstract][Full Text] [Related]
46. Human monoclonal antibody by an established human-human hybridoma.
Tsuji K; Ikewaki N; Matsuno N
Transplant Proc; 1987 Feb; 19(1 Pt 1):610-1. PubMed ID: 2856298
[No Abstract] [Full Text] [Related]
47. Establishment of Novel Monoclonal Fabs Specific for Epstein-Barr Virus Encoded Latent Membrane Protein 1.
Li G; Ding L; Ma X; Cai Q; Ying T; Wei F
Virol Sin; 2019 Aug; 34(4):467-470. PubMed ID: 30949961
[No Abstract] [Full Text] [Related]
48. Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class II-antigens.
Faggione A; Zompetta C; Cirone M; Barile G; Frati L; Acolla R
Int J Cancer; 1990 May; 45(5):989. PubMed ID: 2159443
[No Abstract] [Full Text] [Related]
49. Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3.
Tsoukas CD; Fox RI; Carson DA; Fong S; Vaughan JH
Cell Immunol; 1982 May; 69(1):113-21. PubMed ID: 6286147
[No Abstract] [Full Text] [Related]
50. Interleukin-1-like activity produced by hybrids constructed with Epstein-Barr-virus-transformed human B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Pacciardi A; Tarantino E
Int Arch Allergy Appl Immunol; 1988; 85(1):76-81. PubMed ID: 2828240
[TBL] [Abstract][Full Text] [Related]
51. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.
Kaplan D; Smith D; Meyerson H; Pecora N; Lewandowska K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13850-3. PubMed ID: 11707593
[TBL] [Abstract][Full Text] [Related]
52. A flow cytometric technique for quantitation of B-cell activation.
Garner JG; Colvin RB; Schooley RT
J Immunol Methods; 1984 Feb; 67(1):37-51. PubMed ID: 6321600
[TBL] [Abstract][Full Text] [Related]
53. Human lymphoid cell transformation by Epstein-Barr virus.
Pope JH; Scott W; Moss DJ
Nat New Biol; 1973 Dec; 246(153):140-1. PubMed ID: 4357390
[No Abstract] [Full Text] [Related]
54. Normal immunosuppressive protein: inhibitory effect on hemagglutinin and plaque formation as well as B cell transformation by Epstein-Barr virus.
Nelken D; Ovadia H
Experientia; 1982 Aug; 38(8):963-5. PubMed ID: 6182020
[No Abstract] [Full Text] [Related]
55. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
Thorley-Lawson DA; Strominger JL
Virology; 1978 May; 86(2):423-31. PubMed ID: 208257
[No Abstract] [Full Text] [Related]
56. Epstein-Barr virus receptors on human pharyngeal epithelia.
Young LS; Clark D; Sixbey JW; Rickinson AB
Lancet; 1986 Feb; 1(8475):240-2. PubMed ID: 2868257
[TBL] [Abstract][Full Text] [Related]
57. C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr Virus.
Schulz T; Dierich MP; Yefenof E; Klein G
Cell Immunol; 1980 Apr; 51(1):168-72. PubMed ID: 6244899
[No Abstract] [Full Text] [Related]
58. Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma.
Wyatt DE; Coyle PV
J Clin Pathol; 1991 Nov; 44(11):966. PubMed ID: 1661303
[No Abstract] [Full Text] [Related]
59. Selective transformation of B lymphocytes by E.B. virus.
Pattengale PK; Smith RW; Gerber P
Lancet; 1973 Jul; 2(7820):93-4. PubMed ID: 4123640
[No Abstract] [Full Text] [Related]
60. Abnormal responsiveness of rheumatoid B cells to Epstein-Barr virus infection in vitro.
Stierle HE; Brown KA; Perry JD; Holborow EJ
Lancet; 1981 Dec; 2(8259):1347. PubMed ID: 6118742
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
